Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 171

1.

S-nitrosoglutathione-containing hydrogel increases dermal blood flow in streptozotocin-induced diabetic rats.

Seabra AB, Pankotai E, Fehér M, Somlai A, Kiss L, Bíró L, Szabó C, Kollai M, de Oliveira MG, Lacza Z.

Br J Dermatol. 2007 May;156(5):814-8. Epub 2007 Jan 30.

PMID:
17263816
2.

Topically applied S-nitrosothiol-containing hydrogels as experimental and pharmacological nitric oxide donors in human skin.

Seabra AB, Fitzpatrick A, Paul J, De Oliveira MG, Weller R.

Br J Dermatol. 2004 Nov;151(5):977-83.

PMID:
15541075
3.

Effects of chronic exercise on endothelial dysfunction and insulin signaling of cutaneous microvascular in streptozotocin-induced diabetic rats.

Heidarianpour A, Hajizadeh S, Khoshbaten A, Niaki AG, Bigdili MR, Pourkhalili K.

Eur J Cardiovasc Prev Rehabil. 2007 Dec;14(6):746-52.

PMID:
18043294
4.

Nitric oxide donor improves healing if applied on inflammatory and proliferative phase.

Amadeu TP, Seabra AB, de Oliveira MG, Monte-Alto-Costa A.

J Surg Res. 2008 Sep;149(1):84-93. doi: 10.1016/j.jss.2007.10.015. Epub 2007 Nov 29.

PMID:
18374944
5.

Vasodilator effects of adenosine on retinal arterioles in streptozotocin-induced diabetic rats.

Nakazawa T, Mori A, Saito M, Sakamoto K, Nakahara T, Ishii K.

Naunyn Schmiedebergs Arch Pharmacol. 2008 Feb;376(6):423-30. Epub 2007 Dec 19.

PMID:
18092153
6.

Preservation of pressure-induced cutaneous vasodilation by limiting oxidative stress in short-term diabetic mice.

Demiot C, Fromy B, Saumet JL, Sigaudo-Roussel D.

Cardiovasc Res. 2006 Jan;69(1):245-52. Epub 2005 Nov 2.

PMID:
16266692
7.

Early endothelial dysfunction severely impairs skin blood flow response to local pressure application in streptozotocin-induced diabetic mice.

Sigaudo-Roussel D, Demiot C, Fromy B, Koïtka A, Lefthériotis G, Abraham P, Saumet JL.

Diabetes. 2004 Jun;53(6):1564-9.

8.

S-nitrosoglutathione-containing hydrogel accelerates rat cutaneous wound repair.

Amadeu TP, Seabra AB, de Oliveira MG, Costa AM.

J Eur Acad Dermatol Venereol. 2007 May;21(5):629-37.

PMID:
17447976
9.

S-nitrosoglutathione inhibits inducible nitric oxide synthase upregulation by redox posttranslational modification in experimental diabetic retinopathy.

Rosales MA, Silva KC, Duarte DA, de Oliveira MG, de Souza GF, Catharino RR, Ferreira MS, Lopes de Faria JB, Lopes de Faria JM.

Invest Ophthalmol Vis Sci. 2014 May 2;55(5):2921-32. doi: 10.1167/iovs.13-13762.

PMID:
24699383
10.

Poly(vinyl alcohol) films for topical delivery of S-nitrosoglutathione: effect of freezing-thawing on the diffusion properties.

Simões MM, de Oliveira MG.

J Biomed Mater Res B Appl Biomater. 2010 May;93(2):416-24. doi: 10.1002/jbm.b.31598.

PMID:
20101734
11.

Skin vasodilation and analgesic effect of a topical nitric oxide-releasing hydrogel.

Vercelino R, Cunha TM, Ferreira ES, Cunha FQ, Ferreira SH, de Oliveira MG.

J Mater Sci Mater Med. 2013 Sep;24(9):2157-69. doi: 10.1007/s10856-013-4973-7. Epub 2013 Jun 12.

PMID:
23756965
12.

Topical methyl nicotinate-induced skin vasodilation in diabetic neuropathy.

Caselli A, Hanane T, Jane B, Carter S, Khaodhiar L, Veves A.

J Diabetes Complications. 2003 Jul-Aug;17(4):205-10.

PMID:
12810244
13.

Topical S-nitrosoglutathione-releasing hydrogel improves healing of rat ischaemic wounds.

Georgii JL, Amadeu TP, Seabra AB, de Oliveira MG, Monte-Alto-Costa A.

J Tissue Eng Regen Med. 2011 Aug;5(8):612-9. doi: 10.1002/term.353. Epub 2010 Dec 29.

PMID:
21774084
14.

Modulation of glucose uptake in adipose tissue by nitric oxide-generating compounds.

McGrowder D, Ragoobirsingh D, Brown P.

J Biosci. 2006 Sep;31(3):347-54.

15.

Dose-dependent vasodilatory effects of acetylcholine and local warming on skin microcirculation.

Christen S, Delachaux A, Dischl B, Golay S, Liaudet L, Feihl F, Waeber B.

J Cardiovasc Pharmacol. 2004 Dec;44(6):659-64.

PMID:
15550784
16.

Neurogenic cutaneous vasodilatation and plasma extravasation in diabetic rats: effect of insulin and nerve growth factor.

Bennett GS, Garrett NE, Diemel LT, Brain SD, Tomlinson DR.

Br J Pharmacol. 1998 Aug;124(7):1573-9.

17.

Chronic inhibition of inducible nitric oxide synthase ameliorates cardiovascular abnormalities in streptozotocin diabetic rats.

Nagareddy PR, McNeill JH, MacLeod KM.

Eur J Pharmacol. 2009 Jun 2;611(1-3):53-9. doi: 10.1016/j.ejphar.2009.03.061. Epub 2009 Apr 1.

PMID:
19344709
18.

Effect of isoflurane on skin-pressure-induced vasodilation.

Fizanne L, Fromy B, Preckel MP, Sigaudo-Roussel D, Saumet JL.

J Vasc Res. 2003 Jul-Aug;40(4):416-22. Epub 2003 Aug 12.

PMID:
12913334
19.

Effects of sildenafil on oxidative and inflammatory injuries of the kidney in streptozotocin-induced diabetic rats.

Jeong KH, Lee TW, Ihm CG, Lee SH, Moon JY, Lim SJ.

Am J Nephrol. 2009;29(3):274-82. doi: 10.1159/000158635. Epub 2008 Sep 24.

PMID:
18812693
20.

Mulberry leaf extract restores arterial pressure in streptozotocin-induced chronic diabetic rats.

Naowaboot J, Pannangpetch P, Kukongviriyapan V, Kukongviriyapan U, Nakmareong S, Itharat A.

Nutr Res. 2009 Aug;29(8):602-8. doi: 10.1016/j.nutres.2009.06.002.

PMID:
19761895

Supplemental Content

Support Center